Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Accumulated Expenses (2019 - 2026)

Updated

Aligos Therapeutics' Accumulated Expenses was $15.15 million in Q3 2026, up 11.3% from $13.61 million a year earlier but down 19.0% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Aligos Therapeutics came in at $13.53 million, down 13.1% from FY2024.

  • Accumulated Expenses shows a five-year compound annual growth rate of -4.0% (FY2020 to FY2025).
  • In earlier years, Accumulated Expenses was $15.56 million in FY2024 (-7.6%), $16.84 million in FY2023 (+5.0%), $16.04 million in FY2022 (-36.8%) and $25.39 million in FY2021 (+53.3%).
  • Quarterly Accumulated Expenses has moved between $11 million (Q1 2025) and $25.39 million (Q4 2021) over five years.
  • Compared with a year earlier, Accumulated Expenses has increased for three straight quarters, with growth averaging 5.2% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Expenses over five years was Q1 2022 (growth of 56.6%); the worst was Q3 2022 (a decline of 39.9%).
  • Per Business Quant data, ALGS's Accumulated Expenses in the three quarters before Q3 2026 was $18.7 million (Q2 2026), $11.99 million (Q1 2026) and $13.53 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.15 Mn
Jun 30, 2026 18.70 Mn
Mar 31, 2026 11.99 Mn
Dec 31, 2025 13.53 Mn
Sep 30, 2025 13.61 Mn
Jun 30, 2025 12.21 Mn
Mar 31, 2025 11.00 Mn
Dec 31, 2024 15.56 Mn
Sep 30, 2024 14.16 Mn
Jun 30, 2024 12.06 Mn
Mar 31, 2024 12.04 Mn
Dec 31, 2023 16.84 Mn
Sep 30, 2023 12.32 Mn
Jun 30, 2023 13.80 Mn
Mar 31, 2023 15.08 Mn
Dec 31, 2022 16.04 Mn
Sep 30, 2022 13.68 Mn
Jun 30, 2022 12.82 Mn
Mar 31, 2022 19.24 Mn
Dec 31, 2021 25.39 Mn
API Access

Aligos Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY